Fibromyalgia

Kelley's Textbook of Rheumatology: Volume 1-2, Ninth Edition

Volumn 1, Issue , 2012, Pages 733-751

  Wolfe, Frederick ^a,b   Rasker, Johannes J ^c  

^a NATIONAL DATA BANK FOR RHEUMATIC DISEASES   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84905001095     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-1738-9.00052-9     Document Type: Chapter

References (308)

1. KP White (2004) Fibromyalgia: the answer is blowin' in the wind. J Rheumatol 31(4), 636-639
2. F Wolfe (2009) Fibromyalgia wars. J Rheumatol 36(4), 671-678
3. F Wolfe, D Clauw, MA Fitzcharles, et al. (2010) The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 62(5), 600-610
4. F Wolfe, HA Smythe, MB Yunus, et al. (1990) The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33(2), 160-172
5. P Henningsen, S Zipfel and W Herzog (2007) Management of functional somatic syndromes. Lancet 369(9565), 946-955
6. AJ Barsky and JF Borus (1999) Functional somatic syndromes. Ann Intern Med 130(11), 910-921
7. S Wessely, C Nimnuan and M Sharpe (1999) Functional somatic syndromes: one or many? Lancet 354(9182), 936-939
8. M Sharpe and A Carson (2001) “Unexplained” somatic symptoms, functional syndromes, and somatization: do we need a paradigm shift? Ann Intern Med 134(9 Pt 2), 926-930
9. P Fink and A Schroder (2010) One single diagnosis, bodily distress syndrome, succeeded to capture 10 diagnostic categories of functional somatic syndromes and somatoform disorders. J Psychosom Res 68(5), 415-426
10. K Leiknes, A Finset and T Moum (2010) Commonalities and differences between the diagnostic groups: current somatoform disorders, anxiety and/or depression, and musculoskeletal disorders. J Psychosom Res 68 439-446
11. S Wessely and M Hotopf (1999) Is fibromyalgia a distinct clinical entity? Historical and epidemiological evidence. Baillieres Best Pract Res Clin Rheumatol 13(3), 427-436
12. F Wolfe, D Clauw, MA Fitzcharles, et al. (2011) Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia. J Rheumatol 38 1113-1122
13. F Wolfe and K Michaud (2011) The National Data Bank for rheumatic diseases: a multi-registry rheumatic disease data bank. Rheumatology (Oxford) 50 16-24
14. F Wolfe, D Clauw, MA Fitzcharles, et al. (2010) The ACR fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia. Arthritis Care Res 62 600-610
15. S Reid, D Whooley, T Crayford and M Hotopf (2001) Medically unexplained symptoms—GPs' attitudes towards their cause and management. Fam Pract 18(5), 519-523
16. R Smith (2002) In search of “non-disease”. BMJ 324(7342), 883-885
17. E Shorter (1992) From paralysis to fatigue: a history of psychosomatic illness in the modern era. New York: The Free Press
18. F Wolfe (1997) The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic. Ann Rheum Dis 56(4), 268-271
19. GJ Macfarlane, S Morris, IM Hunt, et al. (1999) Chronic widespread pain in the community: the influence of psychological symptoms and mental disorder on healthcare seeking behavior. J Rheumatol 26(2), 413-419
20. GJ Macfarlane (1999) Generalized pain, fibromyalgia and regional pain: an epidemiological view. Baillieres Best Pract Res Clin Rheumatol 13(3), 403-414
21. E Shorter (1994) From the mind into the body: the cultural origins of psychosomatic symptoms. New York: The Free Press
22. I Hacking (1999) The social construction of what? Boston: Harvard University Press
23. P Conrad (2005) The shifting engines of medicalization. J Health Social Behavior 46(1), 3
24. P Conrad (2007) The medicalization of society. Baltimore: Johns Hopkins University Press
25. I Illich (2000) Limits to medicine: medical nemesis, the expropriation of health. New York: Marion Boyars Publishers Ltd
26. K Ablin and DJ Clauw (2009) From fibrositis to functional somatic syndromes to a bell-shaped curve of pain and sensory sensitivity: evolution of a clinical construct. Rheum Dis Clin North Am 35(2), 233-251
27. R Moynihan, I Heath and D Henry (2002) Selling sickness: the pharmaceutical industry and disease mongering. BMJ 324(7342), 886-891
28. RM Poses Who supports fibromyalgia patient advocacy? http://hcrenewal.blogspot.com/2009/02/who-supports-fibromyalgia-patient.html Accessed February 23, 2012 (website). Available at
29. HA Smythe and H Moldofsky (1977) Two contributions to understanding of the “fibrositis” syndrome. Bull Rheum Dis 28 928-931
30. M Yunus, AT Masi, JJ Calabro, et al. (1981) Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 11(1), 151-171
31. GE Ehrlich (2003) Pain is real; fibromyalgia isn't. J Rheumatol 30(8), 1666-1667
32. NM Hadler and S Greenhalgh (2005) Labeling woefulness: the social construction of fibromyalgia. Spine 30(1), 1-4
33. NM Hadler (2003) “Fibromyalgia” and the medicalization of misery. J Rheumatol 30(8), 1668-1670
34. I Hazemeijer and JJ Rasker (2003) Fibromyalgia and the therapeutic domain. A philosophical study on the origins of fibromyalgia in a specific social setting. Rheumatology (Oxford) 42(4), 507-515
35. SR Block (1993) Fibromyalgia and the rheumatisms. Common sense and sensibility. Rheum Dis Clin North Am 19(1), 61-78
36. JL Quintner and ML Cohen (1999) Fibromyalgia falls foul of a fallacy. Lancet 353(9158), 1092-1094
37. ML Cohen and JL Quintner (1993) Fibromyalgia syndrome, a problem of tautology. Lancet 342 906-909
38. LJ Crofford and DJ Clauw (2002) Fibromyalgia: where are we a decade after the American College of Rheumatology classification criteria were developed? Arthritis Rheum 46(5), 1136-1138
39. F Wolfe (1989) Fibromyalgia: the clinical syndrome. Rheum Dis Clin North Am 15 1-18
40. DC Park, JM Glass, M Minear and LJ Crofford (2001) Cognitive function in fibromyalgia patients. Arthritis Rheum 44(9), 2125-2133
41. F Wolfe and DJ Hawley (1999) Evidence of disordered symptom appraisal in fibromyalgia: increased rates of reported comorbidity and comorbidity severity. Clin Exp Rheumatol 17(3), 297-303
42. F Wolfe, K Michaud, T Li and BS Katz (2010) Chronic conditions and health problems in rheumatic diseases: comparisons with RA, non-inflammatory rheumatic disorders, systemic lupus erythematosus and fibromyalgia. J Rheumatol 37 305-315
43. F Wolfe and JJ Rasker (2006) The Symptom Intensity Scale, fibromyalgia, and the meaning of fibromyalgia-like symptoms. J Rheumatol 33(11), 2291-2299
44. J McBeth and AJ Silman (2001) The role of psychiatric disorders in fibromyalgia. Curr Rheumatol Rep 3(2), 157-164
45. N Uceyler, W Hauser and C Sommer (2009) [Fibromyalgia syndrome: diagnostic criteria and treatment]. MMW Fortschr Med 151(36), 46-49
46. F Wolfe (2010) New criteria for fibromyalgia: a twenty year journey. Arthritis Care Res 62(5), 583-584
47. JF Fries, PW Spitz, RG Kraines and HR Holman (1980) Measurement of patient outcome in arthritis. Arthritis Rheum 23 137-145
48. F Wolfe, K Michaud and T Pincus (2004) Development and validation of the health assessment questionnaire II: a revised version of the health assessment questionnaire. Arthritis Rheum 50(10), 3296-3305
49. T Pincus, C Swearingen and F Wolfe (1999) Toward a multidimensional Health Assessment Questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format. Arthritis Rheum 42(10), 2220-2230
50. CS Burckhardt, SR Clark and RM Bennett (1991) The fibromyalgia impact questionnaire: development and validation. J Rheumatol 18(5), 728-733
51. R Bennett (2005) The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol 23(5 Suppl 39), S154-S162
52. R Bennett, R Friend, K Jones, et al. (2009) The revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther 11(5), 415
53. A Hidding, M van Santen, E De Klerk, et al. (1994) Comparison between self-report measures and clinical observations of functional disability in ankylosing spondylitis, rheumatoid arthritis and fibromyalgia. J Rheumatol 21(5), 818-823
54. EH Choy, LM Arnold, D Clauw, et al. (2009) Content and criterion validity of the preliminary core dataset for clinical trials in fibromyalgia syndrome. J Rheumatol 36 2330
55. JE Ware and CD Sherbourne (1992) The MOS 36-Item Short-Form Health Survey (SF-36).1. Conceptual Framework and Item Selection. Med Care 30 473-483
56. F Wolfe, K Michaud, T Li and RS Katz (2010) EQ-5D and SF-36 quality of life measures in systemic lupus erythematosus: comparisons with RA, non-inflammatory rheumatic disorders, and fibromyalgia. J Rheumatol 37 296-304
57. F Wolfe, AF Hassett, RS Katz and K Michaud (2011) Do we need core sets of fibromyalgia domains? The assessment of fibromyalgia (and other rheumatic disorders) in clinical practice. J Rheumatol 38 1104-1112
58. JW Jacobs, JJ Rasker, A Van der Heide, et al. (1996) Lack of correlation between the mean tender point score and self-reported pain in fibromyalgia. Arthritis Care Res 9(2), 105-111
59. RW Simms, DL Goldenberg, DT Felson and JH Mason (1988) Tenderness in 75 anatomic sites. Distinguishing fibromyalgia patients from controls. Arthritis Rheum 31 182-187
60. F Wolfe (1994) When to diagnose fibromyalgia. Rheum Dis Clin N Am 20 485-501
61. AA Fischer and ES Rachlin (1994) Pressure algometry (dolorimetry) in the differential diagnosis of muscle pain. Myofascial pain and fibromyalgia: trigger point management. St. Louis: Mosby pp 121–140
62. J Branco, B Bannwarth, I Failde, et al. (Eds) (2009) Prevalence of fibromyalgia: a survey in five European countries St Louis: Elsevier
63. F Wolfe, K Ross, J Anderson, et al. (1995) The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38(1), 19-28
64. KG Raphael, MN Janal, S Nayak, et al. (2006) Psychiatric comorbidities in a community sample of women with fibromyalgia. Pain 124(1-2), 117-125
65. KP White, M Speechley, M Harth and T Ostbyte (1999) The London Fibromyalgia Epidemiology Study: the prevalence of fibromyalgia syndrome in London, Ontario. J Rheumatol 26(7), 1570-1576
66. SA Haq, J Darmawan, MN Islam, et al. (2005) Prevalence of rheumatic diseases and associated outcomes in rural and urban communities in Bangladesh: a COPCORD study. J Rheumatol 32(2), 348-353
67. A Farooqi and T Gibson (1998) Prevalence of the major rheumatic disorders in the adult population of north Pakistan. Br J Rheumatol 37(5), 491-495
68. F Salaffi, R De Angelis and W Grassi (2005) Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study. Clin Exp Rheumatol 23(6), 819-828
69. M Topbas, H Cakirbay, H Gulec, et al. (2005) The prevalence of fibromyalgia in women aged 20-64 in Turkey. Scand J Rheumatol 34(2), 140-144
70. ER Senna, AL De Barros, EO Silva, et al. (2004) Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach. J Rheumatol 31(3), 594-597
71. L Lindell, S Bergman, IF Petersson, et al. (2000) Prevalence of fibromyalgia and chronic widespread pain. Scand J Primary Health Care 18(3), 149-153
72. P Clark, R BurgosVargas, C MedinaPalma, et al. (1998) Prevalence of fibromyalgia in children: a clinical study of Mexican children. J Rheumatol 25(10), 2009-2014
73. M Mikkelsson (1999) One year outcome of preadolescents with fibromyalgia. J Rheumatol 26(3), 674-682
74. D Buskila, L Neumann, E Hershman, et al. (1995) Fibromyalgia syndrome in children—an outcome study. J Rheumatol 22(3), 525-528
75. SM Campbell, S Clark, EA Tindall, et al. (1983) Clinical characteristics of fibrositis. I. A “blinded,” controlled study of symptoms and tender points. Arthritis Rheum 26 817-824
76. A Hartz and E Kirchdoerfer (1987) Undetected fibrositis in primary care practice. J Fam Pract 25 365-369
77. F Wolfe and MA Cathey (1983) Prevalence of primary and secondary fibrositis. J Rheumatol 10 965-968
78. W Hauser, G Schmutzer, E Brahler and H Glaesmer (2009) A cluster within the continuum of biopsychosocial distress can be labeled “fibromyalgia syndrome”—evidence from a representative German population survey. J Rheumatol 36(12), 2806-2812
79. RS Katz, F Wolfe and K Michaud (2006) Fibromyalgia diagnosis: a comparison of clinical, survey, and American College of Rheumatology criteria. Arthritis Rheum 54(1), 169-176
80. F Wolfe (2003) Pain extent and diagnosis: development and validation of the regional pain scale in 12,799 patients with rheumatic disease. J Rheumatol 30(2), 369-378
81. D Williams and D Clauw (2009) Understanding fibromyalgia: lessons from the broader pain research community. J Pain 10(8), 777-791
82. D Williams and R Gracely (2007) Biology and therapy of fibromyalgia. Functional magnetic resonance imaging findings in fibromyalgia. Arthritis Res Ther 8(6), 224
83. K Kato, P Sullivan, B Evengård and N Pedersen (2008) A population-based twin study of functional somatic syndromes. Psychol Med 39(03), 497-505
84. LM Arnold, JI Hudson, EV Hess, et al. (2004) Family study of fibromyalgia. Arthritis Rheum 50(3), 944-952
85. N Uceyler, R Valenza, M Stock, et al. (2006) Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain. Arthritis Rheum 54(8), 2656-2664
86. SA Epstein, G Kay, D Clauw, et al. (1999) Psychiatric disorders in patients with fibromyalgia. A multicenter investigation. Psychosomatics 40(1), 57-63
87. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association
88. S Roizenblatt, H Moldofsky, AA Benedito-Silva and S Tufik (2001) Alpha sleep characteristics in fibromyalgia. Arthritis Rheum 44(1), 222-230
89. S Bergman, P Herrstrom, K Hogstrom, et al. (2001) Chronic musculoskeletal pain, prevalence rates, and sociodemographic associations in a Swedish population study. J Rheumatol 28(6), 1369-1377
90. EN Griep, JW Boersma and ER de Kloet (1993) Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheumatol 20(3), 469-474
91. G Neeck and W Riedel (1992) Thyroid function in patients with fibromyalgia syndrome. J Rheumatol 19(7), 1120-1122
92. R Dinser, T Halama and A Hoffmann (2000) Stringent endocrinological testing reveals subnormal growth hormone secretion in some patients with fibromyalgia syndrome but rarely severe growth hormone deficiency. J Rheumatol 27(10), 2482-2488
93. F Petzke and DJ Clauw (2000) Sympathetic nervous system function in fibromyalgia. Curr Rheumatol Rep 2(2), 116-123
94. M Martinez-Lavin (2001) Is fibromyalgia a generalized reflex sympathetic dystrophy? Clin Exp Rheumatol 19(1), 1-3
95. R Staud, CJ Vierck, RL Cannon, et al. (2001) Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain 91(1-2), 165-175
96. P Mease (2005) Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol 75(Suppl), 6-21
97. R Kwiatek, L Barnden, R Tedman, et al. (2000) Regional cerebral blood flow in fibromyalgia: single-photon-emission computed tomography evidence of reduction in the pontine tegmentum and thalami. Arthritis Rheum 43(12), 2823-2833
98. E Werle, HP Fischer, A Muller, et al. (2001) Antibodies against serotonin have no diagnostic relevance in patients with fibromyalgia syndrome. J Rheumatol 28(3), 595-600
99. R Staud (2006) Biology and therapy of fibromyalgia: pain in fibromyalgia syndrome. Arthritis Res Ther 8(3), 208
100. H El-Gabalawy and L Ryner (2008) Central nervous system abnormalities in fibromyalgia: assessment using proton magnetic resonance spectroscopy. J Rheumatol 35(7), 1242-1244
101. A Schoedel, K Zimmermann, H Handwerker and C Forster (2008) The influence of simultaneous ratings on cortical BOLD effects during painful and non-painful stimulation. Pain 135(1-2), 131-141
102. JM Mountz, LA Bradley, JG Modell, et al. (1995) Fibromyalgia in women. Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum 38(7), 926-938
103. RH Gracely, F Petzke, JM Wolf and DJ Clauw (2002) Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 46(5), 1333-1343
104. DB Cook, G Lange, DS Ciccone, et al. (2004) Functional imaging of pain in patients with primary fibromyalgia. J Rheumatol 31(2), 364-378
105. Y Emad, Y Ragab, F Zeinhom, et al. (2008) Hippocampus dysfunction may explain symptoms of fibromyalgia syndrome. A study with single-voxel magnetic resonance spectroscopy. J Rheumatol 35(7), 1371-1377
106. P Wood, C Ledbetter, M Glabus, et al. (2009) Hippocampal metabolite abnormalities in fibromyalgia: correlation with clinical features. J Pain 10(1), 47
107. M Petrou, R Harris, B Foerster, et al. (2008) Proton MR spectroscopy in the evaluation of cerebral metabolism in patients with fibromyalgia: comparison with healthy controls and correlation with symptom severity. Am J Neuroradiol 29(5), 913
108. A Kuchinad, P Schweinhardt, D Seminowicz, et al. (2007) Accelerated brain gray matter loss in fibromyalgia patients: premature aging of the brain? J Neurosci 27(15), 4004
109. N Boutros and A Belger (1999) Midlatency evoked potentials attenuation and augmentation reflect different aspects of sensory gating. Biol Psychiatry 45(7), 917-922
110. P Montoya, C Sitges, M Garcia-Herrera, et al. (2006) Reduced brain habituation to somatosensory stimulation in patients with fibromyalgia. Arthritis Rheum 54(6), 1995-2003
111. DL Goldenberg, RW Simms, A Geiger and AL Komaroff (1990) High frequency of fibromyalgia in patients with chronic fatigue seen in a primary care practice. Arthritis Rheum 33 381-387
112. R Kerns, D Turk and T Rudy (1985) The West Haven-Yale multidimensional pain inventory (WHYMPI). Pain 23(4), 345-356
113. P Montoya, C Sitges, M Garcia-Herrera, et al. (2005) Abnormal affective modulation of somatosensory brain processing among patients with fibromyalgia. Psychosom Med 67(6), 957-963
114. P Montoya, P Pauli, A Batra and G Wiedemann (2005) Altered processing of pain-related information in patients with fibromyalgia. Eur J Pain 9(3), 293-303
115. DD Price and R Staud (2005) Neurobiology of fibromyalgia syndrome. J Rheumatol 75(Suppl), 22-28
116. N Julien, P Goffaux, P Arsenault and S Marchand (2005) Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain 114(1-2), 295-302
117. S Lautenbacher and GB Rollman (1997) Possible deficiencies of pain modulation in fibromyalgia. Clin J Pain 13(3), 189-196
118. PB Wood, JC Patterson 2nd, JJ Sunderland, et al. (2007) Reduced presynaptic dopamine activity in fibromyalgia syndrome demonstrated with positron emission tomography: a pilot study. J Pain 8(1), 51-58
119. RE Harris, DJ Clauw, DJ Scott, et al. (2007) Decreased central mu-opioid receptor availability in fibromyalgia. J Neurosci 27(37), 10000-10006
120. I Tracey (2008) Imaging pain. Br J Anaesth 101(1), 32
121. KP White (2004) Fibromyalgia: the answer is blowin' in the wind. J Rheumatol 31(4), 636-639
122. F Wolfe (2009) Fibromyalgia wars. J Rheumatol 36(4), 671-678
123. F Wolfe, D Clauw, MA Fitzcharles, et al. (2010) The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 62(5), 600-610
124. F Wolfe, HA Smythe, MB Yunus, et al. (1990) The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33(2), 160-172
125. P Henningsen, S Zipfel and W Herzog (2007) Management of functional somatic syndromes. Lancet 369(9565), 946-955
126. AJ Barsky and JF Borus (1999) Functional somatic syndromes. Ann Intern Med 130(11), 910-921
127. S Wessely, C Nimnuan and M Sharpe (1999) Functional somatic syndromes: one or many? Lancet 354(9182), 936-939
128. M Sharpe and A Carson (2001) “Unexplained” somatic symptoms, functional syndromes, and somatization: do we need a paradigm shift? Ann Intern Med 134(9 Pt 2), 926-930
129. P Fink and A Schroder (2010) One single diagnosis, bodily distress syndrome, succeeded to capture 10 diagnostic categories of functional somatic syndromes and somatoform disorders. J Psychosom Res 68(5), 415-426
130. K Leiknes, A Finset and T Moum (2010) Commonalities and differences between the diagnostic groups: current somatoform disorders, anxiety and/or depression, and musculoskeletal disorders. J Psychosom Res 68 439-446
131. S Wessely and M Hotopf (1999) Is fibromyalgia a distinct clinical entity? Historical and epidemiological evidence. Baillieres Best Pract Res Clin Rheumatol 13(3), 427-436
132. F Wolfe, D Clauw, MA Fitzcharles, et al. (2011) Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia. J Rheumatol 38 1113-1122
133. F Wolfe and K Michaud (2011) The National Data Bank for rheumatic diseases: a multi-registry rheumatic disease data bank. Rheumatology (Oxford) 50 16-24
134. F Wolfe, D Clauw, MA Fitzcharles, et al. (2010) The ACR fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia. Arthritis Care Res 62 600-610
135. S Reid, D Whooley, T Crayford and M Hotopf (2001) Medically unexplained symptoms—GPs' attitudes towards their cause and management. Fam Pract 18(5), 519-523
136. R Smith (2002) In search of “non-disease”. BMJ 324(7342), 883-885
137. E Shorter (1992) From paralysis to fatigue: a history of psychosomatic illness in the modern era. New York: The Free Press
138. F Wolfe (1997) The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic. Ann Rheum Dis 56(4), 268-271
139. GJ Macfarlane, S Morris, IM Hunt, et al. (1999) Chronic widespread pain in the community: the influence of psychological symptoms and mental disorder on healthcare seeking behavior. J Rheumatol 26(2), 413-419
140. GJ Macfarlane (1999) Generalized pain, fibromyalgia and regional pain: an epidemiological view. Baillieres Best Pract Res Clin Rheumatol 13(3), 403-414
141. E Shorter (1994) From the mind into the body: the cultural origins of psychosomatic symptoms. New York: The Free Press
142. I Hacking (1999) The social construction of what? Boston: Harvard University Press
143. P Conrad (2005) The shifting engines of medicalization. J Health Social Behavior 46(1), 3
144. P Conrad (2007) The medicalization of society. Baltimore: Johns Hopkins University Press
145. I Illich (2000) Limits to medicine: medical nemesis, the expropriation of health. New York: Marion Boyars Publishers Ltd
146. K Ablin and DJ Clauw (2009) From fibrositis to functional somatic syndromes to a bell-shaped curve of pain and sensory sensitivity: evolution of a clinical construct. Rheum Dis Clin North Am 35(2), 233-251
147. R Moynihan, I Heath and D Henry (2002) Selling sickness: the pharmaceutical industry and disease mongering. BMJ 324(7342), 886-891
148. RM Poses Who supports fibromyalgia patient advocacy? http://hcrenewal.blogspot.com/2009/02/who-supports-fibromyalgia-patient.html Accessed February 23, 2012 (website). Available at
149. HA Smythe and H Moldofsky (1977) Two contributions to understanding of the “fibrositis” syndrome. Bull Rheum Dis 28 928-931
150. M Yunus, AT Masi, JJ Calabro, et al. (1981) Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 11(1), 151-171
151. GE Ehrlich (2003) Pain is real; fibromyalgia isn't. J Rheumatol 30(8), 1666-1667
152. NM Hadler and S Greenhalgh (2005) Labeling woefulness: the social construction of fibromyalgia. Spine 30(1), 1-4
153. NM Hadler (2003) “Fibromyalgia” and the medicalization of misery. J Rheumatol 30(8), 1668-1670
154. I Hazemeijer and JJ Rasker (2003) Fibromyalgia and the therapeutic domain. A philosophical study on the origins of fibromyalgia in a specific social setting. Rheumatology (Oxford) 42(4), 507-515
155. SR Block (1993) Fibromyalgia and the rheumatisms. Common sense and sensibility. Rheum Dis Clin North Am 19(1), 61-78
156. JL Quintner and ML Cohen (1999) Fibromyalgia falls foul of a fallacy. Lancet 353(9158), 1092-1094
157. ML Cohen and JL Quintner (1993) Fibromyalgia syndrome, a problem of tautology. Lancet 342 906-909
158. LJ Crofford and DJ Clauw (2002) Fibromyalgia: where are we a decade after the American College of Rheumatology classification criteria were developed? Arthritis Rheum 46(5), 1136-1138
159. F Wolfe (1989) Fibromyalgia: the clinical syndrome. Rheum Dis Clin North Am 15 1-18
160. DC Park, JM Glass, M Minear and LJ Crofford (2001) Cognitive function in fibromyalgia patients. Arthritis Rheum 44(9), 2125-2133
161. F Wolfe and DJ Hawley (1999) Evidence of disordered symptom appraisal in fibromyalgia: increased rates of reported comorbidity and comorbidity severity. Clin Exp Rheumatol 17(3), 297-303
162. F Wolfe, K Michaud, T Li and BS Katz (2010) Chronic conditions and health problems in rheumatic diseases: comparisons with RA, non-inflammatory rheumatic disorders, systemic lupus erythematosus and fibromyalgia. J Rheumatol 37 305-315
163. F Wolfe and JJ Rasker (2006) The Symptom Intensity Scale, fibromyalgia, and the meaning of fibromyalgia-like symptoms. J Rheumatol 33(11), 2291-2299
164. J McBeth and AJ Silman (2001) The role of psychiatric disorders in fibromyalgia. Curr Rheumatol Rep 3(2), 157-164
165. N Uceyler, W Hauser and C Sommer (2009) [Fibromyalgia syndrome: diagnostic criteria and treatment]. MMW Fortschr Med 151(36), 46-49
166. F Wolfe (2010) New criteria for fibromyalgia: a twenty year journey. Arthritis Care Res 62(5), 583-584
167. JF Fries, PW Spitz, RG Kraines and HR Holman (1980) Measurement of patient outcome in arthritis. Arthritis Rheum 23 137-145
168. F Wolfe, K Michaud and T Pincus (2004) Development and validation of the health assessment questionnaire II: a revised version of the health assessment questionnaire. Arthritis Rheum 50(10), 3296-3305
169. T Pincus, C Swearingen and F Wolfe (1999) Toward a multidimensional Health Assessment Questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format. Arthritis Rheum 42(10), 2220-2230
170. CS Burckhardt, SR Clark and RM Bennett (1991) The fibromyalgia impact questionnaire: development and validation. J Rheumatol 18(5), 728-733
171. R Bennett (2005) The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol 23(5 Suppl 39), S154-S162
172. R Bennett, R Friend, K Jones, et al. (2009) The revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther 11(5), 415
173. A Hidding, M van Santen, E De Klerk, et al. (1994) Comparison between self-report measures and clinical observations of functional disability in ankylosing spondylitis, rheumatoid arthritis and fibromyalgia. J Rheumatol 21(5), 818-823
174. EH Choy, LM Arnold, D Clauw, et al. (2009) Content and criterion validity of the preliminary core dataset for clinical trials in fibromyalgia syndrome. J Rheumatol 36 2330
175. JE Ware and CD Sherbourne (1992) The MOS 36-Item Short-Form Health Survey (SF-36).1. Conceptual Framework and Item Selection. Med Care 30 473-483
176. F Wolfe, K Michaud, T Li and RS Katz (2010) EQ-5D and SF-36 quality of life measures in systemic lupus erythematosus: comparisons with RA, non-inflammatory rheumatic disorders, and fibromyalgia. J Rheumatol 37 296-304
177. F Wolfe, AF Hassett, RS Katz and K Michaud (2011) Do we need core sets of fibromyalgia domains? The assessment of fibromyalgia (and other rheumatic disorders) in clinical practice. J Rheumatol 38 1104-1112
178. JW Jacobs, JJ Rasker, A Van der Heide, et al. (1996) Lack of correlation between the mean tender point score and self-reported pain in fibromyalgia. Arthritis Care Res 9(2), 105-111
179. RW Simms, DL Goldenberg, DT Felson and JH Mason (1988) Tenderness in 75 anatomic sites. Distinguishing fibromyalgia patients from controls. Arthritis Rheum 31 182-187
180. F Wolfe (1994) When to diagnose fibromyalgia. Rheum Dis Clin N Am 20 485-501
181. AA Fischer and ES Rachlin (1994) Pressure algometry (dolorimetry) in the differential diagnosis of muscle pain. Myofascial pain and fibromyalgia: trigger point management. St. Louis: Mosby pp 121–140
182. J Branco, B Bannwarth, I Failde, et al. (Eds) (2009) Prevalence of fibromyalgia: a survey in five European countries St Louis: Elsevier
183. F Wolfe, K Ross, J Anderson, et al. (1995) The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38(1), 19-28
184. KG Raphael, MN Janal, S Nayak, et al. (2006) Psychiatric comorbidities in a community sample of women with fibromyalgia. Pain 124(1-2), 117-125
185. KP White, M Speechley, M Harth and T Ostbyte (1999) The London Fibromyalgia Epidemiology Study: the prevalence of fibromyalgia syndrome in London, Ontario. J Rheumatol 26(7), 1570-1576
186. SA Haq, J Darmawan, MN Islam, et al. (2005) Prevalence of rheumatic diseases and associated outcomes in rural and urban communities in Bangladesh: a COPCORD study. J Rheumatol 32(2), 348-353
187. A Farooqi and T Gibson (1998) Prevalence of the major rheumatic disorders in the adult population of north Pakistan. Br J Rheumatol 37(5), 491-495
188. F Salaffi, R De Angelis and W Grassi (2005) Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study. Clin Exp Rheumatol 23(6), 819-828
189. M Topbas, H Cakirbay, H Gulec, et al. (2005) The prevalence of fibromyalgia in women aged 20-64 in Turkey. Scand J Rheumatol 34(2), 140-144
190. ER Senna, AL De Barros, EO Silva, et al. (2004) Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach. J Rheumatol 31(3), 594-597
191. L Lindell, S Bergman, IF Petersson, et al. (2000) Prevalence of fibromyalgia and chronic widespread pain. Scand J Primary Health Care 18(3), 149-153
192. P Clark, R BurgosVargas, C MedinaPalma, et al. (1998) Prevalence of fibromyalgia in children: a clinical study of Mexican children. J Rheumatol 25(10), 2009-2014
193. M Mikkelsson (1999) One year outcome of preadolescents with fibromyalgia. J Rheumatol 26(3), 674-682
194. D Buskila, L Neumann, E Hershman, et al. (1995) Fibromyalgia syndrome in children—an outcome study. J Rheumatol 22(3), 525-528
195. SM Campbell, S Clark, EA Tindall, et al. (1983) Clinical characteristics of fibrositis. I. A “blinded,” controlled study of symptoms and tender points. Arthritis Rheum 26 817-824
196. A Hartz and E Kirchdoerfer (1987) Undetected fibrositis in primary care practice. J Fam Pract 25 365-369
197. F Wolfe and MA Cathey (1983) Prevalence of primary and secondary fibrositis. J Rheumatol 10 965-968
198. W Hauser, G Schmutzer, E Brahler and H Glaesmer (2009) A cluster within the continuum of biopsychosocial distress can be labeled “fibromyalgia syndrome”—evidence from a representative German population survey. J Rheumatol 36(12), 2806-2812
199. RS Katz, F Wolfe and K Michaud (2006) Fibromyalgia diagnosis: a comparison of clinical, survey, and American College of Rheumatology criteria. Arthritis Rheum 54(1), 169-176
200. F Wolfe (2003) Pain extent and diagnosis: development and validation of the regional pain scale in 12,799 patients with rheumatic disease. J Rheumatol 30(2), 369-378
201. D Williams and D Clauw (2009) Understanding fibromyalgia: lessons from the broader pain research community. J Pain 10(8), 777-791
202. D Williams and R Gracely (2007) Biology and therapy of fibromyalgia. Functional magnetic resonance imaging findings in fibromyalgia. Arthritis Res Ther 8(6), 224
203. K Kato, P Sullivan, B Evengård and N Pedersen (2008) A population-based twin study of functional somatic syndromes. Psychol Med 39(03), 497-505
204. LM Arnold, JI Hudson, EV Hess, et al. (2004) Family study of fibromyalgia. Arthritis Rheum 50(3), 944-952
205. N Uceyler, R Valenza, M Stock, et al. (2006) Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain. Arthritis Rheum 54(8), 2656-2664
206. SA Epstein, G Kay, D Clauw, et al. (1999) Psychiatric disorders in patients with fibromyalgia. A multicenter investigation. Psychosomatics 40(1), 57-63
207. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association
208. S Roizenblatt, H Moldofsky, AA Benedito-Silva and S Tufik (2001) Alpha sleep characteristics in fibromyalgia. Arthritis Rheum 44(1), 222-230
209. S Bergman, P Herrstrom, K Hogstrom, et al. (2001) Chronic musculoskeletal pain, prevalence rates, and sociodemographic associations in a Swedish population study. J Rheumatol 28(6), 1369-1377
210. EN Griep, JW Boersma and ER de Kloet (1993) Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheumatol 20(3), 469-474
211. G Neeck and W Riedel (1992) Thyroid function in patients with fibromyalgia syndrome. J Rheumatol 19(7), 1120-1122
212. R Dinser, T Halama and A Hoffmann (2000) Stringent endocrinological testing reveals subnormal growth hormone secretion in some patients with fibromyalgia syndrome but rarely severe growth hormone deficiency. J Rheumatol 27(10), 2482-2488
213. F Petzke and DJ Clauw (2000) Sympathetic nervous system function in fibromyalgia. Curr Rheumatol Rep 2(2), 116-123
214. M Martinez-Lavin (2001) Is fibromyalgia a generalized reflex sympathetic dystrophy? Clin Exp Rheumatol 19(1), 1-3
215. R Staud, CJ Vierck, RL Cannon, et al. (2001) Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain 91(1-2), 165-175
216. P Mease (2005) Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol 75(Suppl), 6-21
217. R Kwiatek, L Barnden, R Tedman, et al. (2000) Regional cerebral blood flow in fibromyalgia: single-photon-emission computed tomography evidence of reduction in the pontine tegmentum and thalami. Arthritis Rheum 43(12), 2823-2833
218. E Werle, HP Fischer, A Muller, et al. (2001) Antibodies against serotonin have no diagnostic relevance in patients with fibromyalgia syndrome. J Rheumatol 28(3), 595-600
219. R Staud (2006) Biology and therapy of fibromyalgia: pain in fibromyalgia syndrome. Arthritis Res Ther 8(3), 208
220. H El-Gabalawy and L Ryner (2008) Central nervous system abnormalities in fibromyalgia: assessment using proton magnetic resonance spectroscopy. J Rheumatol 35(7), 1242-1244
221. A Schoedel, K Zimmermann, H Handwerker and C Forster (2008) The influence of simultaneous ratings on cortical BOLD effects during painful and non-painful stimulation. Pain 135(1-2), 131-141
222. JM Mountz, LA Bradley, JG Modell, et al. (1995) Fibromyalgia in women. Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum 38(7), 926-938
223. RH Gracely, F Petzke, JM Wolf and DJ Clauw (2002) Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 46(5), 1333-1343
224. DB Cook, G Lange, DS Ciccone, et al. (2004) Functional imaging of pain in patients with primary fibromyalgia. J Rheumatol 31(2), 364-378
225. Y Emad, Y Ragab, F Zeinhom, et al. (2008) Hippocampus dysfunction may explain symptoms of fibromyalgia syndrome. A study with single-voxel magnetic resonance spectroscopy. J Rheumatol 35(7), 1371-1377
226. P Wood, C Ledbetter, M Glabus, et al. (2009) Hippocampal metabolite abnormalities in fibromyalgia: correlation with clinical features. J Pain 10(1), 47
227. M Petrou, R Harris, B Foerster, et al. (2008) Proton MR spectroscopy in the evaluation of cerebral metabolism in patients with fibromyalgia: comparison with healthy controls and correlation with symptom severity. Am J Neuroradiol 29(5), 913
228. A Kuchinad, P Schweinhardt, D Seminowicz, et al. (2007) Accelerated brain gray matter loss in fibromyalgia patients: premature aging of the brain? J Neurosci 27(15), 4004
229. N Boutros and A Belger (1999) Midlatency evoked potentials attenuation and augmentation reflect different aspects of sensory gating. Biol Psychiatry 45(7), 917-922
230. P Montoya, C Sitges, M Garcia-Herrera, et al. (2006) Reduced brain habituation to somatosensory stimulation in patients with fibromyalgia. Arthritis Rheum 54(6), 1995-2003
231. DL Goldenberg, RW Simms, A Geiger and AL Komaroff (1990) High frequency of fibromyalgia in patients with chronic fatigue seen in a primary care practice. Arthritis Rheum 33 381-387
232. R Kerns, D Turk and T Rudy (1985) The West Haven-Yale multidimensional pain inventory (WHYMPI). Pain 23(4), 345-356
233. P Montoya, C Sitges, M Garcia-Herrera, et al. (2005) Abnormal affective modulation of somatosensory brain processing among patients with fibromyalgia. Psychosom Med 67(6), 957-963
234. P Montoya, P Pauli, A Batra and G Wiedemann (2005) Altered processing of pain-related information in patients with fibromyalgia. Eur J Pain 9(3), 293-303
235. DD Price and R Staud (2005) Neurobiology of fibromyalgia syndrome. J Rheumatol 75(Suppl), 22-28
236. N Julien, P Goffaux, P Arsenault and S Marchand (2005) Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain 114(1-2), 295-302
237. S Lautenbacher and GB Rollman (1997) Possible deficiencies of pain modulation in fibromyalgia. Clin J Pain 13(3), 189-196
238. PB Wood, JC Patterson 2nd, JJ Sunderland, et al. (2007) Reduced presynaptic dopamine activity in fibromyalgia syndrome demonstrated with positron emission tomography: a pilot study. J Pain 8(1), 51-58
239. RE Harris, DJ Clauw, DJ Scott, et al. (2007) Decreased central mu-opioid receptor availability in fibromyalgia. J Neurosci 27(37), 10000-10006
240. I Tracey (2008) Imaging pain. Br J Anaesth 101(1), 32
241. E Baumgartner, A Finckh, C Cedraschi and TL Vischer (2002) A six year prospective study of a cohort of patients with fibromyalgia. Ann Rheum Dis 61(7), 644-645
242. F Wolfe, J Anderson, D Harkness, et al. (1997) Health status and disease severity in fibromyalgia: results of a six-center longitudinal study. Arthritis Rheum 40(9), 1571-1579
243. F Wolfe, D Clauw, MA Fitzcharles, et al. (2011) Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol 38(6), 1113-1122
244. JR Redondo, CM Justo, FV Moraleda, et al. (2004) Long-term efficacy of therapy in patients with fibromyalgia: a physical exercise-based program and a cognitive-behavioral approach. Arthritis Rheum 51(2), 184-192
245. S Carette, MJ Bell, WJ Reynolds, et al. (1994) Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial. Arthritis Rheum 37(1), 32-40
246. DL Goldenberg, C Burckhardt and L Crofford (2004) Management of fibromyalgia syndrome. JAMA 292(19), 2388-2395
247. SF Carville, S Arendt-Nielsen, H Bliddal, et al. (2008) EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis 67(4), 536-541
248. W Hauser, K Bernardy, B Arnold, et al. (2009) Efficacy of multicomponent treatment in fibromyalgia syndrome: a meta-analysis of randomized controlled clinical trials. Arthritis Rheum 61(2), 216-224
249. W Häuser, K Bernardy, N Uceyler and C Sommer (2009) Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis. JAMA 301(2), 198-209
250. W Hauser, P Klose, J Langhorst, et al. (2010) Efficacy of different types of aerobic exercise in fibromyalgia syndrome: a systematic review and meta-analysis of randomised controlled trials. Arthritis Res Ther 12(3), R79
251. W Hauser, F Petzke and C Sommer (2010) Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome. J Pain 11(6), 505-521
252. W Hauser, K Thieme and DC Turk (2010) Guidelines on the management of fibromyalgia syndrome—a systematic review. Eur J Pain 14(1), 5-10
253. J Langhorst, P Klose, F Musial, et al. (2010) Efficacy of acupuncture in fibromyalgia syndrome—a systematic review with a meta-analysis of controlled clinical trials. Rheumatology (Oxford) 49(4), 778-788
254. LM Arnold, PE Keck and JA Welge (2000) Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics 41(2), 104-113
255. W Häuser, B Arnold, W Eich, et al. (2008) Management of fibromyalgia syndrome—an interdisciplinary evidence-based guideline. Ger Med Sci 6 Doc14
256. G Hughes, C Martinez, E Myon, et al. (2006) The impact of a diagnosis of fibromyalgia on health care resource use by primary care patients in the UK: an observational study based on clinical practice. Arthritis Rheum 54(1), 177-183
257. SE Ross (1999) “Memes” as infectious agents in psychosomatic illness. Ann Intern Med 131 867-870
258. C Cedraschi, J Desmeules, E Rapiti, et al. (2004) Fibromyalgia: a randomised, controlled trial of a treatment programme based on self management. Ann Rheum Dis 63(3), 290-296
259. MM Alamo, RR Moral and LA Perula de Torres (2002) Evaluation of a patient-centred approach in generalized musculoskeletal chronic pain/fibromyalgia patients in primary care. Patient Educ Couns 48(1), 23-31
260. A Pfeiffer, JM Thompson, A Nelson, et al. (2003) Effects of a 1.5-day multidisciplinary outpatient treatment program for fibromyalgia: a pilot study. Am J Phys Med Rehabil 82(3), 186-191
261. A Busch, CL Schachter, PM Peloso and C Bombardier (2002) Exercise for treating fibromyalgia syndrome. Cochrane Database Syst Rev (3), CD003786
262. SC Richards and DL Scott (2002) Prescribed exercise in people with fibromyalgia: parallel group randomised controlled trial. BMJ 325(7357), 185
263. SE Gowans, A deHueck, S Voss, et al. (2004) Six-month and one-year followup of 23 weeks of aerobic exercise for individuals with fibromyalgia. Arthritis Rheum 51(6), 890-898
264. A Busch, K Barber, T Overend, et al. (2007) Exercise for treating fibromyalgia syndrome. Cochrane Database Syst Rev (4), CD003786
265. MR Assis, LE Silva, AM Alves, et al. (2006) A randomized controlled trial of deep water running: clinical effectiveness of aquatic exercise to treat fibromyalgia. Arthritis Rheum 55(1), 57-65
266. SE Gowans and A deHueck (2004) Effectiveness of exercise in management of fibromyalgia. Curr Opin Rheumatol 16(2), 138-142
267. PL Dobkin, D Da Costa, M Abrahamowicz, et al. (2006) Adherence during an individualized home based 12-week exercise program in women with fibromyalgia. J Rheumatol 33(2), 333-341
268. PL Dobkin, M Abrahamowicz, MA Fitzcharles, et al. (2005) Maintenance of exercise in women with fibromyalgia. Arthritis Rheum 53(5), 724-731
269. SH Wigers, TC Stiles and PA Vogel (1996) Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scand J Rheumatol 25(2), 77-86
270. R Bennett and D Nelson (2006) Cognitive behavioral therapy for fibromyalgia. Nat Clin Pract Rheumatol 2(8), 416-424
271. K Thieme, E Gromnica-Ihle and H Flor (2003) Operant behavioral treatment of fibromyalgia: a controlled study. Arthritis Rheum 49(3), 314-320
272. BB Singh, BM Berman, VA Hadhazy and P Creamer (1998) A pilot study of cognitive behavioral therapy in fibromyalgia [see comments]. Altern Ther Health Med 4(2), 67-70
273. KP White and WR Nielson (1995) Cognitive behavioral treatment of fibromyalgia syndrome: a followup assessment. J Rheumatol 22(4), 717-721
274. K Thieme, H Flor and D Turk (2006) Psychological pain treatment in fibromyalgia syndrome: efficacy of operant behavioural and cognitive behavioural treatments. Arthritis Res Ther 8(4), R121
275. VA Hadhazy, J Ezzo, P Creamer and BM Berman (2000) Mind-body therapies for the treatment of fibromyalgia. A systematic review. J Rheumatol 27(12), 2911-2918
276. S Lera, S Gelman, M Lûpez, et al. (2009) Multidisciplinary treatment of fibromyalgia: does cognitive behavior therapy increase the response to treatment? J Pychosomatic Res 67(5), 433-441
277. ME Goossens, MP Rutten-van Molken, RM Leidl, et al. (1996) Cognitive-educational treatment of fibromyalgia: a randomized clinical trial. II. Economic evaluation. J Rheumatol 23(7), 1246-1254
278. JW Vlaeyen, NJ Teeken-Gruben, ME Goossens, et al. (1996) Cognitive-educational treatment of fibromyalgia: a randomized clinical trial. I. Clinical effects. J Rheumatol 23(7), 1237-1245
279. S Van Koulil, M Effting, F Kraaimaat, et al. (2007) Cognitive-behavioural therapies and exercise programmes for patients with fibromyalgia: state of the art and future directions. Br Med J 66(5), 571
280. F Wolfe, J Anderson, D Harkness, et al. (1997) A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthritis Rheum 40(9), 1560-1570
281. DL Goldenberg, DT Felson and H Dinerman (1986) A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthritis Rheum 29 1371-1377
282. RM Bennett, M Kamin, R Karim and N Rosenthal (2003) Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study. Am J Med 114(7), 537-545
283. PG O'Malley, E Balden, G Tomkins, et al. (2000) Treatment of fibromyalgia with antidepressants: a meta-analysis. J Gen Intern Med 15(9), 659-666
284. L Arnold, P.J. Keck PJr and J Welge (2000) Antidepressant treatment of fibromyalgia: a meta-analysis and review. Psychosomatics 41(2), 104
285. S Carette, M Bell, J Reynolds, et al. (1992) A controlled trial of amitriptyline (AM), cyclobenzaprine (CY) and placebo (P) in fibromyalgia. Arthritis Rheum 35 S112
286. AJ Busch, KA Barber, TJ Overend, et al. (2007) Exercise for treating fibromyalgia syndrome. Cochrane Database Syst Rev (4), CD003786
287. HC Haanen, HT Hoenderdos, LK van Romunde, et al. (1991) Controlled trial of hypnotherapy in the treatment of refractory fibromyalgia. J Rheumatol 18(1), 72-75
288. C Deluze, L Bosia, A Zirbs, et al. (1992) Electroacupuncture in fibromyalgia: results of a controlled trial. BMJ 305(6864), 1249-1252
289. NP Assefi, KJ Sherman, C Jacobsen, et al. (2005) A randomized clinical trial of acupuncture compared with sham acupuncture in fibromyalgia. Ann Intern Med 143(1), 10-19
290. AR Drexler, EJ Mur and VC Gunther (2002) Efficacy of an EMG-biofeedback therapy in fibromyalgia patients. A comparative study of patients with and without abnormality in (MMPI) psychological scales. Clin Exp Rheumatol 20(5), 677-682
291. M van Santen, P Bolwijn, F Verstappen, et al. (2002) A randomized clinical trial comparing fitness and biofeedback training versus basic treatment in patients with fibromyalgia. J Rheumatol 29(3), 575-581
292. G Ferraccioli, L Ghirelli, F Scita, et al. (1987) EMG-biofeedback training in fibromyalgia syndrome. J Rheumatol 14(4), 820-825
293. L Altan, U Bingol, M Aykac, et al. (2004) Investigation of the effects of pool-based exercise on fibromyalgia syndrome. Rheumatol Int 24(5), 272-277
294. D Buskila, M Abu-Shakra, L Neumann, et al. (2001) Balneotherapy for fibromyalgia at the Dead Sea. Rheumatol Int 20(3), 105-108
295. TR Zijlstra, MA van de Laar, HJ Bernelot Moens, et al. (2005) Spa treatment for primary fibromyalgia syndrome: a combination of thalassotherapy, exercise and patient education improves symptoms and quality of life. Rheumatology (Oxford) 44(4), 539-546
296. A Hassett and R Gevirtz (2009) Nonpharmacologic treatment for fibromyalgia: patient education, cognitive-behavioral therapy, relaxation techniques, and complementary and alternative medicine. Rheum Dis Clin North Am 35(2), 393-407
297. JC Ballantyne and J Mao (2003) Opioid therapy for chronic pain. N Engl J Med 349(20), 1943-1953
298. TR Zijlstra, LM Braakman-Jansen, E Taal, et al. (2007) Cost-effectiveness of spa treatment for fibromyalgia: general health improvement is not for free. Rheumatology (Oxford) 46(9), 1454-1459
299. A Dônmez, M Karagülle, et al. (2005) Spa therapy in fibromyalgia: a randomised controlled clinic study. Rheumatol Int 26(2), 168-172
300. L Neumann, S Sukenik, A Bolotin, et al. (2001) The effect of balneotherapy at the Dead Sea on the quality of life of patients with fibromyalgia syndrome. Clin Rheumatol 20(1), 15-19
301. J McVeigh, H McGaughey, M Hall and P Kane (2008) The effectiveness of hydrotherapy in the management of fibromyalgia syndrome: a systematic review. Rheumatol Int 29(2), 119-130
302. J Langhorst, F Musial, P Klose and W Hauser (2009) Efficacy of hydrotherapy in fibromyalgia syndrome—a meta-analysis of randomized controlled clinical trials. Rheumatology (Oxford) 48(9), 1155-1159
303. GO Littlejohn and J Walker (2002) A realistic approach to managing patients with fibromyalgia. Curr Rheumatol Rep 4(4), 286-292
304. G Littlejohn (1995) The fibromyalgia syndrome. Outcome is good with minimal intervention. BMJ 310(6991), 1406
305. MA Fitzcharles, DD Costa and R Poyhia (2003) A study of standard care in fibromyalgia syndrome: a favorable outcome. J Rheumatol 30(1), 154-159
306. AM Mengshoel and M Haugen (2001) Health status in fibromyalgia—a followup study. J Rheumatol 28(9), 2085-2089
307. B Walitt, MA Fitzcharles, AL Hassett, et al. (2011) The longitudinal outcome of fibromyalgia: a study of 1,555 patients. J Rheumatol 38 2238-2246
308. V Nöller and H Sprott (2003) Prospective epidemiological observations on the course of the disease in fibromyalgia patients. J Neg Results BioMed 2(1), 4